CGM Overpatch Tapes Market

What is the CGM overpatch tapes market forecast to be worth by 2036?

USD 0.5 billion in 2026 to USD 1.2 billion by 2036, at 9.2% CAGR.

• The CGM overpatch tapes market crossed a valuation of USD 0.4 billion in 2025.
• Demand is expected to increase from USD 0.5 billion in 2026 to USD 1.2 billion by 2036.
• The market is forecast to record 9.2% CAGR from 2026 to 2036 as continuous glucose monitor users seek longer sensor hold, improved comfort and fewer premature sensor losses.

What are the defining numbers behind CGM overpatch tapes market growth?

USD 0.7 billion absolute opportunity by 2036, led by CGM sensor retention and recurring adhesive accessory use.

• Demand Drivers in the Market
  • CGM users need tapes that keep sensors secure through showering, sweating and sleep.
  • Diabetes educators need simple retention options for users who face early sensor lifting.
  • DTC patch brands need device-specific designs for Dexcom, Libre and Medtronic users.
  • Online channels need refill packs that match continuous sensor replacement cycles.
• Key Segments Analyzed
  • By Wear Duration: 10-14-day overpatches are expected to hold 44.0% share in 2026 because they align with common CGM wear cycles.
  • By Device Compatibility: Dexcom-compatible tapes lead because device-specific DTC demand is strong. The segment is projected to capture 37.0% share in 2026.
  • By Wear Environment: Sweatproof sports tapes are likely to account for 34.0% share in 2026 because active users need stronger sensor retention.
  • By Channel: DTC brand sites lead because users search by sensor type, pattern and wear need. The segment is expected to hold 35.0% share in 2026.
  • By Geography: The United States is projected to record 10.6% CAGR through 2036 as CGM accessory buying shifts toward DTC and Amazon channels.
• Analyst Opinion at Fact.MR
  • Shambhu Nath Jha, Senior Analyst at Fact.MR, states, “CGM overpatch tapes are small products, but they solve a large user problem. When a sensor lifts early, the user loses confidence in the device experience. Brands that combine secure hold, correct cutout design and comfortable removal will be better placed than brands selling generic tape.”
• Strategic Implications
  • Overpatch brands should design by sensor model instead of selling broad adhesive shapes.
  • Diabetes clinics should guide new CGM users on safe overpatch placement.
  • DTC brands should match refill packs with sensor wear cycles and activity needs.
  • Pharmacies should separate CGM overpatch tapes from ordinary first-aid tapes.

CGM overpatch tapes sit below the wider diabetes management ecosystem because they support CGM use, but they are not software or sensors. The category differs from underpatch products because overpatch tapes are placed over or around the sensor adhesive to improve retention after device placement.

The American Diabetes Association’s 2026 Standards release recommends continuous glucose monitoring at diabetes onset and anytime thereafter for people who can benefit from its use in diabetes management. [1] This supports the scope because CGM overpatch tapes are accessory products tied to continuous sensor use, not standalone glucose monitoring devices.

The United States is projected to record 10.6% CAGR through 2036 as Dexcom and Pump Peelz support recurring patch purchases. Germany is expected to post 10.1% CAGR through 2036 as diabetes device users seek adhesive support through pharmacy and online channels. Japan is likely to record 9.7% CAGR as discreet wearable support becomes important for daily sensor wear. China is forecast to advance at 9.3% CAGR as online CGM accessory discovery expands. India is set to record 8.9% CAGR as private diabetes clinics and e-commerce channels improve CGM accessory access.

How does the CGM overpatch tapes market break down by segment?

10-14-day overpatches lead at 44.0%; Dexcom-compatible tapes lead at 37.0%.

Which wear duration dominates?

10-14-day overpatches hold 44.0% share in 2026.

10-14-day overpatches are expected to hold 44.0% share in 2026 because users want tapes that can match the full sensor wear period. Shorter 3-day tapes suit temporary reinforcement, while 7-day tapes are useful where users replace adhesive support mid-cycle. Sweatproof sports tapes address exercise and outdoor activity. Pediatric tapes support children and teens who need comfort and design choice. Dexcom’s official guidance on the G7 15 Day system highlights longer continuous wear and fewer sensor changes. [2]

Which device compatibility dominates?

Dexcom-compatible tapes lead with 37.0% share in 2026.

Dexcom-compatible tapes lead because users search for patch shapes that match G6, G7 and Stelo devices. The segment is projected to capture 37.0% share in 2026 as DTC brands build product pages around Dexcom sensor families. Abbott FreeStyle Libre-compatible tapes follow because Libre has broad global use. Medtronic Guardian-compatible tapes serve insulin-dependent users. Universal cutouts support shoppers who want one patch family across devices. Abbott guidance states that the sensor opening must not be covered when an over-bandage is used.[3]

Which wear environment dominates?

Sweatproof sports tapes hold 34.0% share in 2026.

Sweatproof sports tapes lead because exercise, heat and water exposure can weaken sensor adhesion. The wear environment segment is likely to account for 34.0% share in 2026 as users look for stronger hold during workouts and outdoor activity. Daily wear tapes support ordinary sensor retention. Shower-safe tapes address water exposure. Sleep-wear tapes reduce edge lifting overnight. Pediatric school-wear tapes support play, sports and classroom routines. The segment connects with wearable adhesives because overpatch performance is shaped by comfort and long-wear adhesion.

Which channel dominates?

DTC brand sites lead with 35.0% share in 2026.

DTC brand sites lead because users search by device, color, shape and activity need. The channel is expected to hold 35.0% share in 2026 as brands sell refill packs, patterned tapes and bundles directly. Amazon supports discovery and reviews. Pharmacies and medical distributors support clinical trust. Diabetes educators and clinics influence first-time product selection. Subscription refills grow where users align tape delivery with sensor cycles. Skin Grip’s 2025 adhesive guidance describes sweat, showers, workouts and swimming as common reasons device adhesives can peel early. [4]

What is accelerating CGM overpatch tape adoption, and what is holding it back?

Rising CGM use and sweatproof wear needs are driving adoption, while incorrect application and skin reaction variability restrain it.

Drivers Impact Analysis

• Rising CGM use
  • Rising CGM use is the strongest demand base because every sensor cycle creates a retention need. Users who face peeling, sweating or accidental sensor movement often add an overpatch. This makes the category recurring. It is commercially tied to CGM device adoption, but it stays separate from the sensor itself.
• Sweatproof and water-resistant use
  • Sweatproof and water-resistant use supports demand because CGMs are worn through workouts, showers and humid weather. Users want tapes that hold without feeling harsh on skin. ExpressionMed states that perfect CGM or pump tape wear time is shaped by material quality, skin quality and external environment. [5] This shows why lifestyle durability is central to the overpatch category.
• DTC and Amazon discovery
  • DTC and Amazon channels help users find the right patch by device model and wear need. A Dexcom G7 user may need a different cutout than a Libre 3 user. Reviews help shoppers compare hold, comfort and removal. This channel structure favors brands with clear naming and strong product imagery.
• Pediatric and teen use
  • Pediatric and teen CGM users need tapes that are secure and comfortable. Design choice matters because children may feel more confident wearing colorful or themed patches. Parents also want products that stay on during school, sports and sleep. This driver supports patterned tapes and smaller-size product lines.
• Subscription refill packs
  • Subscription refill packs support repeat purchase because CGM users need tapes as long as they wear sensors. Monthly packs can match device cycles and reduce missed purchases. Refill models also allow brands to offer seasonal colors, sports-strength packs and sensitive-skin options.

Opportunity Impact Analysis

• Device-specific bundles
  • Device-specific bundles reduce wrong-size purchases. A bundle can include tapes designed for Dexcom, Libre or Stelo users with clear application instructions. This helps users avoid covering openings or interfering with sensor placement. The opportunity is strongest for DTC brands that already sell by device model.
• Sweatproof sports packs
  • Sweatproof sports packs create opportunity for users who exercise, swim or live in humid climates. These packs can use stronger adhesive and flexible materials. Active users want patches that stay secure without creating removal pain. This supports premium positioning around sport, heat and water exposure.
• Pediatric design packs
  • Pediatric design packs can improve acceptance among children and teens. Bright patterns and smaller shapes help users feel comfortable with the sensor. These packs also help parents manage school and sports routines. The opportunity connects with implantable glucose monitors because continuous monitoring behavior creates recurring accessory needs across device types.
• Subscription refills
  • Subscription refills can align overpatch delivery with sensor replacement schedules. This reduces the risk of users running out of tapes mid-cycle. Refill packs can be segmented by sport, sensitive skin or device shape. The opportunity connects with insulin pumps because pump and CGM users often buy adhesive accessories across several wearable devices.

Restraints Impact Analysis

• Incorrect application risk
  • Incorrect application is the main restraint because an overpatch must not block the sensor opening or interfere with device removal. Users may apply the wrong shape or cover the wrong area. This can reduce confidence in the product. Clear diagrams and device-specific instructions are needed to protect adoption.
• Skin reaction variability
  • Skin reaction varies by user, adhesive material and wear duration. A tape that holds strongly may irritate sensitive skin. A gentle tape may lift early in heat or sweat. Brands need multiple material options and skin-prep guidance. The restraint is strongest among users who already experience adhesive sensitivity.
• Compatibility confusion
  • Compatibility confusion can slow purchase because CGM models differ in shape and sensor housing. Users may buy a patch for the wrong Dexcom or Libre version. This issue is common on marketplaces with many listings. Strong product naming and cutout diagrams can reduce confusion.
• Generic tape price pressure
  • Generic medical and athletic tapes create price pressure. Some users will choose cheaper options if they only need extra hold. Dedicated CGM overpatch brands must prove better fit, comfort and sensor-safe design. The restraint connects with pressure sensitive adhesives because adhesive cost and performance shape price competition.

Which countries are scaling CGM overpatch tapes fastest?

United States 10.6%; Germany 10.1%; Japan 9.7%; China 9.3%; India 8.9%.

Based on regional analysis, the CGM overpatch tapes market is segmented into North America, Europe, East Asia, South Asia, Latin America, and Middle East and Africa.

What is powering the United States lead?

10.6% CAGR, driven by Skin Grip and strong CGM accessory DTC buying.

The United States is projected to record 10.6% CAGR from 2026 to 2036 as CGM users buy overpatch tapes through DTC sites, Amazon and pharmacy-linked channels. Dexcom and Pump Peelz create repeated accessory demand. Growth will favor tapes that stay secure through sweat, showering and daily movement.

How is Germany scaling CGM overpatch tape demand?

Germany is scaling through structured diabetes care and pharmacy-led device support.

CGM users need tapes that support sensor retention without creating skin burden. Germany is expected to post 10.1% CAGR through 2036 as diabetes educators and pharmacies increase accessory awareness. Growth will favor hypoallergenic formats and clearly labeled device compatibility.

What supports Japan’s outlook?

9.7% CAGR, driven by compact wearable use and discreet sensor support.

Japan is likely to record 9.7% CAGR by 2036 as CGM users seek thin and discreet overpatch tapes for daily wear. Transparent films and gentle adhesives will gain attention. Brands with compact shapes and clean removal behavior will be better placed.

What underpins China’s growth?

China is scaling through urban CGM adoption and e-commerce accessory discovery.

China is forecast to advance at 9.3% CAGR through 2036 as online channels expand access to diabetes wearable accessories. Users will seek overpatch tapes for sweat protection, sensor hold and everyday comfort. Localized sizing and device-specific listings will shape adoption.

How is India scaling CGM overpatch tape adoption?

8.9% CAGR, driven by private diabetes clinics and online CGM accessory access.

India is set to record 8.9% CAGR by 2036 as private clinics and urban consumers adopt CGM for diabetes and metabolic monitoring. Overpatch demand will grow where heat, sweat and activity affect sensor wear. Affordable multipacks and Amazon availability will matter for repeat purchase.

Who leads the CGM overpatch tapes market?

Skin Grip and ExpressionMed lead through device-specific adhesive patch portfolios.

CGM overpatch tapes are supplied by DTC diabetes accessory brands, adhesive patch specialists and device ecosystem participants. Skin Grip competes through CGM and diabetes-device adhesive patches. ExpressionMed is highly relevant through device-specific tapes and patterned patch designs. GrifGrips competes through adhesive patches for CGMs, insulin pumps and infusion sets. Not Just a Patch is positioned around waterproof and skin-friendly CGM tape.

Dexcom and Pump Peelz shape accessory demand because patch sizing and application behavior follow sensor design. Their role is indirect, but device adoption creates accessory pull. Competition also connects with adhesive tapes because generic tape alternatives stay available when users only need extra hold.

Competition through 2036 will depend on sensor compatibility, adhesive durability, waterproof performance and user education. Brands that sell generic cutouts will face price pressure. Brands that solve sensor-loss anxiety can defend stronger value. The category also connects with medical adhesive tapes because comfort and removal behavior shape user loyalty.

Which companies are the key providers?

Skin Grip and ExpressionMed are key providers. GrifGrips and Not Just a Patch are also profiled. Dexcom and Pump Peelz complete the company set.

• Skin Grip
• ExpressionMed
• GrifGrips
• Not Just a Patch
• Dexcom
• Pump Peelz

Bibliography

• American Diabetes Association. (2025, December 8). The American Diabetes Association releases Standards of Care in Diabetes—2026. American Diabetes Association.
• Dexcom. (2025, December 1). New Dexcom G7 15 Day CGM: Longer wear time, more convenience. Dexcom.
• Dexcom. (2025, April 10). Dexcom G7 15 Day receives FDA clearance: The longest-lasting wearable and most accurate CGM system. Dexcom.
• Abbott. (2025). Can an over-bandage be used with the sensor? FreeStyle Libre.
• Skin Grip. (2026). Diabetic tape adhesive patches for CGM and insulin pumps. Skin Grip.

This Report Addresses

• Strategic intelligence on CGM overpatch tapes across wear duration and device compatibility.
• Segment analysis covering 10-14-day Overpatches and Dexcom-compatible Tapes.
• Regional outlook covering the United States, Germany, Japan, China and India.
• Competitive analysis of Skin Grip, ExpressionMed, GrifGrips, Not Just a Patch, Dexcom and Pump Peelz.
• Technology assessment covering waterproof adhesion, sensor cutouts, hypoallergenic tapes and long-wear retention.
• Use case assessment covering daily wear, sweat protection, showering, sleep wear and pediatric use.
• Primary interviews, provider checks and official source review support the forecast.

What does the CGM overpatch tapes market cover?

Adhesive cover tapes used to secure CGM sensors during wear.

The CGM overpatch tapes market covers 3-day tapes, 7-day tapes, 10-14-day overpatches, sweatproof sports tapes and pediatric tapes. These products are used to keep CGM sensors attached during daily activity, exercise, showering and sleep.

The market differs from broad blood glucose monitoring because it excludes sensors, readers, transmitters and glucose apps. It focuses only on adhesive overpatch tapes and sensor cover formats used to support CGM wear.

What is included in the scope?

Device-specific and universal overpatch tapes used with CGM sensors.

The scope includes tapes designed for Dexcom, Abbott FreeStyle Libre, Medtronic Guardian, Stelo, Lingo and universal CGM cutout formats. It also includes sweatproof sports tapes, pediatric tapes, transparent tapes, patterned tapes and subscription refill formats.

The scope includes products sold through DTC brand sites, Amazon, pharmacies, medical distributors, diabetes educators and clinics. The category connects with skin-adhesive materialsbecause adhesive chemistry controls hold, comfort and removal behavior.

What is excluded from the scope?

CGM sensors, underpatches and diabetes management apps are outside the scope.

The scope excludes CGM sensors and diabetes software. It also excludes underpatches used as skin-facing barriers before sensor application. Broader wireless portable medical devices are outside scope when they are not adhesive retention accessories.

How was the analysis built?

100+ sources, 40+ company portfolios, 25+ countries, 20+ interviews.

• Primary Research:
  • Primary research includes interviews with CGM users and diabetes educators. It includes input from DTC patch brands, pharmacy category managers, endocrinology clinics and e-commerce channel teams.
• Desk Research:
  • Desk research reviews official CGM guidance, overpatch instructions, device-compatibility listings, DTC patch portfolios and Amazon-style product assortments.
• Market-Sizing and Forecasting:
  • Forecasting uses CGM installed base growth, sensor replacement cycles, overpatch attachment rates, refill behavior and device-specific compatibility mapping.
• Data Validation and Update Cycle:
  • Forecasts are validated through provider checks and channel feedback. SKU mapping and product portfolio reviews help confirm market direction.